Citius Oncology, Inc.

NasdaqCM:CTOR Stock Report

Market Cap: US$126.2m

Citius Oncology Balance Sheet Health

Financial Health criteria checks 3/6

Citius Oncology has a total shareholder equity of $17.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $50.0M and $33.0M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
Cashn/a
EquityUS$17.03m
Total liabilitiesUS$32.98m
Total assetsUS$50.01m

Recent financial health updates

No updates

Recent updates

No updates

Financial Position Analysis

Short Term Liabilities: CTOR's short term assets ($10.0M) do not cover its short term liabilities ($31.4M).

Long Term Liabilities: CTOR's short term assets ($10.0M) exceed its long term liabilities ($1.6M).


Debt to Equity History and Analysis

Debt Level: CTOR is debt free.

Reducing Debt: CTOR has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if CTOR has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if CTOR has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies